How GLP-1 Medications Changed the Science and Art of Sustainable Weight Loss with Arne Astrup

The GLP-1 medications transforming weight loss didn’t appear overnight. They’re the result of decades of groundbreaking research that fundamentally changed how we understand appetite and obesity. But how did scientists first discover that this hormone could help people lose weight? And what does this history mean for anyone using these medications today?

Join Holly and Jim as they sit down with Dr. Arne Astrup, one of the pioneering researchers who helped uncover GLP-1’s role in appetite regulation back in the 1990s. Dr. Astrup has spent over three decades at the forefront of obesity research at the University of Copenhagen and the Novo Nordisk Foundation. In this fascinating conversation, he takes us back to when obesity was still seen as a willpower problem, reveals the serendipitous collaboration that led to discovering GLP-1’s satiety effects, and shares critical insights about using these medications safely and effectively.

Whether you’re currently using GLP-1 medications, considering them, or simply curious about the science, this episode offers essential perspective from someone who’s witnessed the entire journey from early physiology experiments to today’s real-world treatments. You’ll discover why lifestyle still matters in the era of highly effective medications, and walk away with a deeper understanding of both the promise and the limitations of these groundbreaking drugs.

Discussed on the episode:

• The surprising mindset shift in the 1990s that changed how medicine views obesity
• Why a diabetes researcher and an appetite scientist became unlikely collaborators
• The first human experiment that proved GLP-1 reduces hunger (and the lunch buffet that made it possible)
• Why GLP-1 medications are so much “cleaner” than previous weight loss drugs
• The protein malnutrition risk that doctors aren’t talking about enough.
• Why half of patients stop taking these medications within months, and what that means
• The one combination that could let you reduce or stop GLP-1s without regaining weight
• Why calling these medications “the easy way out” completely misses the point
• What a leading researcher wants to accomplish after decades of groundbreaking work